These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 6401608

  • 1. Review of fracture experience during treatment of Paget's disease of bone with etidronate disodium (EHDP).
    Johnston CC, Altman RD, Canfield RE, Finerman GA, Taulbee JD, Ebert ML.
    Clin Orthop Relat Res; 1983; (172):186-94. PubMed ID: 6401608
    [No Abstract] [Full Text] [Related]

  • 2. Spontaneous fractures of uninvolved bones in patients with Paget's disease during unduly prolonged treatment with disodium etidronate (EHDP).
    Mautalen C, Gonzalez D, Blumenfeld EL, Santini Araujo E, Schajowicz F.
    Clin Orthop Relat Res; 1986 Jun; (207):150-5. PubMed ID: 3087670
    [Abstract] [Full Text] [Related]

  • 3. [Osteolysis, then fracture of the femur in a Paget's disease patient treated with high-dose disodium etidronate].
    Pinel B, Cambon C, Thomine JM, Cauvin M, Daragon A, Deshayes P.
    Rev Rhum Mal Osteoartic; 1984 Jun; 51(7-8):417-8. PubMed ID: 6436959
    [No Abstract] [Full Text] [Related]

  • 4. Use of etidronate (EHDP) in Paget's disease of bone.
    Johnston CC, Khairi MR, Meunier PJ.
    Arthritis Rheum; 1980 Oct; 23(10):1172-6. PubMed ID: 6775643
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Etidronate disodium for Paget's disease.
    Med Lett Drugs Ther; 1978 Sep 08; 20(18):78-9. PubMed ID: 99647
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Risedronate for Paget's disease of bone.
    Med Lett Drugs Ther; 1998 Aug 28; 40(1034):87-8. PubMed ID: 9731243
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Small doses of etidronate (EHDP) and Paget's disease: meaning and importance of the decrease in plasmatic 25(OH)D3.
    D'Amore M, Carrozzo M, Cantatore FP, Scagliusi P, Pipitone V.
    Panminerva Med; 1984 Aug 28; 26(1):13-7. PubMed ID: 6233523
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Experience with sodium etidronate in the treatment of symptomatic Paget's disease of bone.
    Bourke J, Murphy M, Fennelly JJ.
    Ir Med J; 1985 Oct 28; 78(10):300. PubMed ID: 3934108
    [No Abstract] [Full Text] [Related]

  • 15. Paget's disease of bone. Experience with a diphosphonate (disodium etidronate) in treatment.
    Smith R, Russell RG, Bishop MC, Woods CG, Bishop M.
    Q J Med; 1973 Apr 28; 42(166):235-56. PubMed ID: 4206518
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of Paget's disease of bone (osteitis deformans) with sodium etidronate (EHDP).
    Rashid M, Khairi A, Johnston C.
    Clin Orthop Relat Res; 1977 Apr 28; (127):94-105. PubMed ID: 410576
    [No Abstract] [Full Text] [Related]

  • 19. Results of prolonged treatment of Paget's disease of bone with disodium ethane-1-hydroxy-1, 1-diphosphonate (EHDP).
    De Vries HR, Bijvoet OL.
    Neth J Med; 1974 Apr 28; 17(6):281-98. PubMed ID: 4280525
    [No Abstract] [Full Text] [Related]

  • 20. Diphosphonate therapy of paget's disease of bone.
    Canfield R, Rosner W, Skinner J, McWhorter J, Resnick L, Feldman F, Kammerman S, Ryan K, Kunigonis M, Bohne W.
    J Clin Endocrinol Metab; 1977 Jan 28; 44(1):96-106. PubMed ID: 401827
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.